Targeted Genetics Corporation (Nasdaq TGEN): is a biotechnology company committed to the development and commercialization of innovative targeted molecular therapies for the prevention and treatment of inflammatory arthritis and other acquired and inherited diseases with significant unmet medical need. Targeted Genetics has significant expertise in the preclinical development, clinical and regulatory affairs and manufacturing of its innovative gene-based product candidates. The Company has amassed a robust portfolio of intellectual property covering scientific and commercial aspects of its technologies and product development programs.
Website: targen.com |
